MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-06-0026010
Dzire Pharmaceuticals Private Limited
Dzire Pharmaceuticals Private Limited - pharma in Hisar, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.11 Cr
▲ 94% YoY
Net profit · FY 2025
₹19,119
Net margin 0.1%
EBITDA · FY 2025
₹1.32 Lakh
EBITDA margin 0.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹19.8 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Dzire Pharmaceuticals Private Limited
Data last updated:
Dzire Pharmaceuticals Private Limited is a private limited company based in Hisar, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233HR2013PTC050628. Its GSTIN is 06AAECD8883H1ZA (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Bhim Mehta and Pardeep Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 468 GF Rajdarbar Spaces Project Delhi By Pass Hisar, Haryana, India – 125001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.11 Cr, a growth of 94% compared to the previous year. For the same year it recorded a net profit of ₹19,119 (net margin 0.1%) and EBITDA of ₹1.32 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 30% over five years.
As per MCA filings, the company has open charges of ₹19.8 Lakh on record.
Dzire Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-06-0026010). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233HR2013PTC050628
Registration Number 050628
Incorporation Date 08 October 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-06-0026010
Key People
Bhim Mehta Director Pardeep Mehta Director Recognitions & Rankings of Dzire Pharmaceuticals
Contact details
Dzire Pharmaceuticals Private Limited's registered office is in Hisar, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address468 GF Rajdarbar Spaces Project Delhi By Pass Hisar, Haryana, India – 125001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dzire Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dzire Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dzire Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dzire Pharmaceuticals Private Limited, buy the company report.
Financials of Dzire Pharmaceuticals Private Limited
FY 2025 filings availableDzire Pharmaceuticals Private Limited reported revenue of ₹2.11 Cr (up 94% YoY) for FY 2025.
Revenue · FY 2025
₹2.11 Cr ▲ 94%
Net profit · FY 2025
₹19,119 margin 0.1%
EBITDA · FY 2025
₹1.32 Lakh margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 94%
3 years · compounded
▲ 63%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 206%
3 years · compounded
▲ 17%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 94% growth in the latest year. EBITDA rose 206% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,119 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dzire Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dzire Pharmaceuticals Private Limited
Dzire Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhim Mehta | Director | 15 May 2014 | 12 Years 5 Months | Current |
| Pardeep Mehta | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Dzire Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ebc Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | 50.0% | Thrissur, Kerala, India | |||
| Arehk Healthcare Private Limited | ₹2.12 Cr (FY 2024) | 10.0% | Agra, Uttar Pradesh, India | |||
| Dzire Pharmaceuticals Private Limitedthis company | ₹2.11 Cr (FY 2025) | ₹19,119 | 0.1% | 94.0% | Hisar, Haryana, India | |
| Elixir Mediserve Private Limited | ₹2.11 Cr (FY 2025) | -2.0% | Jaipur, Rajasthan, India | |||
| Bioquest Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | 3.0% | New Delhi, Delhi, India | |||
| Genin Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2018) | 364.0% | New Delhii, Delhi, India | |||
| Vib Meditech Private Limited | ₹2.11 Cr (FY 2025) | 4.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Dzire Pharmaceuticals Private Limited, buy the company report.
Auditor
Dzire Pharmaceuticals Private Limited is audited by MEHTANI ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEHTANI ASSOCIATES | FY 2020 | 016667N |
Shareholding
The shareholding of Dzire Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Dzire Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹19.8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Dec 2025 | 101193511 | State Bank of India | ₹10.8 Lakh | Open | |
| 21 Jan 2023 | 100703386 | State Bank of India | ₹9 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Dzire Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dzire Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dzire Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECD8883H1ZA | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dzire Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dzire Pharmaceuticals Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Pawan Kumar ceased to be Director on 18 Sep 2021.
Charges
A charge with State Bank Of India amounted to Rs. 10.80 Lakh with Charge ID 101193511 was registered on 02 Dec 2025.
AGM
Dzire Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dzire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with State Bank Of India amounted to Rs. 9.00 Lakh with Charge ID 100703386 was registered on 21 Jan 2023.
Ceased
Pawan Kumar ceased to be Director.
Appointed
Pardeep Mehta was appointed as Director.
Ceased
Pankaj ceased to be Director.
Appointed
Bhim Mehta was appointed as Director.
Ceased
Sheetal ceased to be Director.
Incorporation
08 Oct 2013
Dzire Pharmaceuticals Private Limited was registered on 08 Oct 2013 with Roc Delhi & aged 13 years 24 days as per MCA records.
Frequently asked questions
Dzire Pharmaceuticals is an active private limited company based in Hisar, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 October 2013 (13+ years old) and is registered under CIN U24233HR2013PTC050628.
Dzire Pharmaceuticals has 2 current directors:
- Bhim Mehta - Director
- Pardeep Mehta - Director
The latest financial statements of Dzire Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dzire Pharmaceuticals is 06AAECD8883H1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Dzire Pharmaceuticals is U24233HR2013PTC050628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dzire Pharmaceuticals was incorporated on 08 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dzire Pharmaceuticals by revenue are Ebc Pharmaceuticals Private Limited, Arehk Healthcare Private Limited, Elixir Mediserve Private Limited, Bioquest Pharmaceuticals Private Limited, Genin Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pawan Kumar ceased to be Director on 18 Sep 2021. Pardeep Mehta was appointed as Director on 17 Sep 2021. Pankaj ceased to be Director on 20 Aug 2014. Dzire Pharmaceuticals has 5 board changes on record in total.
Yes, Dzire Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-06-0026010).
The registered office of Dzire Pharmaceuticals is at 468 GF Rajdarbar Spaces Project Delhi By Pass Hisar, Haryana, India – 125001.
Dzire Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages